In a nutshell This study aimed to investigate the effectiveness of chemotherapy and radiotherapy (CRT) in patients with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL). This study concluded that combined CRT may be more effective in patients with early-stage NLPHL, particularly in older patients. Some background...
Read More
In a nutshell This article outlined recommended treatments for patients with Hodgkin's lymphoma (HL). Some background HL is a type of blood cancer of the lymphatic system. HL can be classified in different ways. In limited HL, cancer is found in one or two sites in the lymphatic system. In advanced HL, cancer is found on both sides of...
Read More
In a nutshell This study evaluated the long-term outcomes of first-line treatment in patients with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL). The authors concluded that survival among these patients was similar to that of the general population. Some background NLPHL is a rare type of Hodgkin lymphoma. When diagnosed, most...
Read More
In a nutshell This article reviewed how useful PET/CT scanning is for patients with Hodgkin's lymphoma (HL) during and after their treatment. Some background Hodgkin's lymphoma (HL) is a cancer of lymphocytes. Lymphocytes are a type of white blood cell that fights infections in the body. For most patients, first-line treatment is highly...
Read More
In a nutshell This study evaluated the effectiveness of radiation, chemotherapy, or both for the treatment of early-stage nodular lymphocyte-predominant Hodgkin’s lymphoma (NLPHL). This study concluded that long-term outcomes were favorable across all treatment approaches. Some background NLPHL is a rare subtype of non-Hodgkin's lymphoma....
Read More
In a nutshell This study aimed to investigate treatments and outcomes for patients with relapsed or unresponsive nodular lymphocyte-predominant Hodgkin lymphoma. This study concluded that these patients have a good overall prognosis and treatments should be chosen individually. Some background Radiotherapy (RT), chemotherapy (CT) and rituximab...
Read More
In a nutshell This study evaluated the outcomes of active surveillance versus upfront treatment for patients with nodular lymphocyte-predominant Hodgkin's lymphoma (NLPHL). It was found that active surveillance is effective for managing NLPHL. Some background NLPHL is a rare subtype of non-Hodgkin's lymphoma. It may be treated with intensive...
Read More
In a nutshell This study evaluated the outcomes of active surveillance versus upfront treatment for patients with nodular lymphocyte-predominant Hodgkin's lymphoma (NLPHL). It was found that active surveillance is effective for managing NLPHL. Some background NLPHL is a rare subtype of non-Hodgkin's lymphoma. It may be treated with intensive...
Read More
